Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29440271 | 1.00 | KDM4E (0.38) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL22125496 | 1.00 | KDM4E (0.38) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL22125078 | 0.96 | KDM4E (0.38) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL29440277 | 0.96 | KDM4E (0.38) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL305044 | 0.82 | CYP1A2 (0.44) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL29460983 | 0.82 | KMT2A (0.49) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL150692 | 0.82 | KMT2A (0.49) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL29351257 | 0.82 | KMT2A (0.49) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL593622 | 0.81 | KMT2A (0.48) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| SCHEMBL593620 | 0.81 | KMT2A (0.48) | KDM4EMEN1ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260023054-A1 | Hydrophilic Interaction Microfluidic Chromatography | PHARMAFLUIDICS NV (BE) | 2026-01-22 | — | — | US | disclosed |
| EP-4681813-A1 | HYDROPHILIC INTERACTION MICROFLUIDIC CHROMATOGRAPHY | PharmaFluidics NV (BE) | 2026-01-21 | — | — | EP | disclosed |
| US-12226494-B2 | Pharmaceutical compositions comprising Gd-complexes and polyarylene additives | BRACCO IMAGING S.P.A. (IT) | 2025-02-18 | — | — | US | disclosed |
| CN-111321174-B | Application of laccase in catalyzing polymerization of methacrylate monomer | 福州大学 | 2022-08-30 | — | — | CN | disclosed |
| US-20220062444-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING GD-COMPLEXES AND POLYARYLENE ADDITIVES | BRACCO IMAGING S.P.A. (IT) | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12226494-B2 | Pharmaceutical compositions comprising Gd-complexes and polyarylene additives | GRN, GALC, ABCB11 | KDM4E 4593/4885MEN1 293/4885ALDH1A1 3585/4885 |
| US-20220062444-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING GD-COMPLEXES AND POLYARYLENE ADDITIVES | GRN, GALC, ABCB11 | KDM4E 4593/4885MEN1 293/4885ALDH1A1 3585/4885 |
| US-20260023054-A1 | Hydrophilic Interaction Microfluidic Chromatography | SRMS, CD69, CDC25A | KDM4E 2008/4885MEN1 1987/4885ALDH1A1 992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.